Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,460 | -110,715 | -19,973 | -14,479 | -8,044 |
| Depreciation Amortization | 265 | 576 | 469 | 413 | 67 |
| Accounts payable and accrued liabilities | 2,715 | -426 | -864 | -810 | 410 |
| Other Working Capital | 3,486 | 4,427 | -2,913 | -2,600 | -1,295 |
| Other Operating Activity | 455 | 76,359 | 2,938 | 2,228 | 403 |
| Operating Cash Flow | $-11,539 | $-29,779 | $-20,343 | $-15,248 | $-8,459 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,887 | -79,807 | 2,000 | 2,000 | 2,000 |
| PPE Investments | -15 | -42 | -52 | 1 | 1 |
| Net Acquisitions | N/A | 29,371 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -3 | 0 | 0 | 0 |
| Investing Cash Flow | $10,872 | $-50,481 | $1,948 | $2,001 | $2,001 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,726 | 1,726 | 1,726 | N/A |
| Common Stock Issued | 1,259 | 25,104 | 24,538 | 19,783 | 19,783 |
| Common Stock Repurchased | N/A | -44 | -1,303 | -1,193 | N/A |
| Other Financing Activity | 0 | 74,525 | -1,333 | -1,333 | -2,068 |
| Financing Cash Flow | $1,259 | $101,311 | $23,628 | $18,983 | $17,715 |
| Beginning Cash Position | 45,897 | 24,846 | 24,846 | 24,846 | 24,846 |
| End Cash Position | 46,489 | 45,897 | 30,079 | 30,582 | 36,103 |
| Net Cash Flow | $592 | $21,051 | $5,233 | $5,736 | $11,257 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,539 | -29,779 | -20,343 | -15,248 | -8,459 |
| Capital Expenditure | -15 | -42 | -53 | N/A | N/A |
| Free Cash Flow | -11,554 | -29,821 | -20,396 | -15,248 | -8,459 |